slide-01 slide-02 Screen4

Technology Platform


VaxInnate's Technology Platform is revolutionizing how vaccines are created and produced.


Product Pipeline


Learn more about our vaccines currently in our development pipeline


In The News

17 Feb 2015 - VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines

- Allows for Non-Dilutive Funding of $53 Million – CRANBURY, NJ – February 17, 2015 – VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology, today announced that it has executed a contract modification with the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) to extend the base […]